Statement on Congressional Appropriations for Vaccine Testing]

.. (, L1 d 4 i-,.& 1 n i*,i

"r. i am.-Ila.

MicroGeneSys,_Ic

~ 'V~MIN'AQ FS ' [QN AAPPROPB1AT }N_\FQ _ VA.( C. 'r~~r
\IER1 DVN, Cf )N\IW:('TICI Y,-()ctobe'r 6, 1992. The 1993 D partrnrt Ac Dete; e
t~rTi'~itv' 0fcn1'rknc 'rep()rt nelu des an addiuonai S t) iou hl bcthe l l) r:se rch
rev crti at the Wtalte~r Reed Aim 1nstiute ct Research WVvRAIR). It IS expected tha2t Thy
addi on I r20() ni tion will he used 'y WRATR to irntuaie. a larg'e-scale Phase Ill etfic acy study of
i~~hde.lco(~rSys AID)S therapeuti. vaccine, V axSyn.
The P h;se IIl study will proceed unless the. Secretary of Defense, the Director of NTH, and
t; e ('nirr. inner of FDA der rrm ie~ that such a study is inappr(pruate: in thy: event, the tuoc s;ti h:'s.wrher AIDS re n- i uneeds:01i theDetense epa rtwent.
Pi L 'tc:I, i 1;: rnC1 t E ft~i sis,!idav 1;'F~-riklmn Id tc vit. C(Thief Exe utive UI> icer.
1. r let il i~ht1 1i the:. QOn L!:. has at dd d $2() M~n n iin the \Vahier Ree%.i Annv Institute of
ct i cv;. est ior Mcro(Gen Svs' Lt 1 6 V acene. VaxS. n Iress v oii~n I&Fi?'i~
rp3OvL forwartd pI'utmpfv on treatmc ruts tor AID)S. and that VaxSvn) is the no:tt-studiicd'vas:c
taret9 dioi research. AIDS is a devasui:i nc disease. affec inP tibe ive.-)o
I ueor(,KISI f lt u:a ds of A~ienn;and rnhinn.s (4 others arounu the woirid.
"The i t VCh w1'tit V'a'x Fyni ha been 'favorable to fdate. 'The mrnev by pite tVthe
CT ~fl55 w!1 ena hie this Phase liI toh C proceed with the urt.enc y that. warraruZec

tii)'I!'i, E:1 i stIPS.

\'axvn yePswrd t au'urirk f NL r eneys.Invc
55710~95.04g6.028

CONFIOLi
II IS ADDRESS.